Siomond Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 9.00 M
as on 08-07-2024
- Paid Up Capital ₹ 6.90 M
as on 08-07-2024
- Company Age 20 Year, 8 Months
- Last Filing with ROC 31 Mar 2016
- Open Charges ₹ 30.00 Cr
as on 08-07-2024
- Satisfied Charges ₹ 48.50 Cr
as on 08-07-2024
- Revenue 235.00%
(FY 2016)
- Profit 95.60%
(FY 2016)
- Ebitda 101.26%
(FY 2016)
- Net Worth -0.01%
(FY 2016)
- Total Assets -30.03%
(FY 2016)
About Siomond Pharmaceuticals
The Company is engaged in the Home & Lifestyle Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2016. It's a company limited by shares with an authorized capital of Rs 9.00 M and a paid-up capital of Rs 6.90 M.
The company currently has active open charges totaling ₹30.00 Cr. The company has closed loans amounting to ₹48.50 Cr, as per Ministry of Corporate Affairs (MCA) records.
Pardeep Thakur and Mohan Thakur serve as directors at the Company.
- CIN/LLPIN
U24239DL2004PTC125540
- Company No.
125540
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2004
- Date of AGM
30 Sep 2016
- Date of Balance Sheet
31 Mar 2016
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
North Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Siomond Pharmaceuticals Private Limited offer?
Siomond Pharmaceuticals Private Limited offers a wide range of products and services, including Common Disease Medicines, Eye Drops.
Who are the key members and board of directors at Siomond Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pardeep Thakur  | Director | 01-Apr-2004 | Current |
| Mohan Thakur | Director | 01-Apr-2004 | Current |
Financial Performance of Siomond Pharmaceuticals.
Siomond Pharmaceuticals Private Limited, for the financial year ended 2016, experienced significant growth in revenue, with a 235% increase. The company also saw a substantial improvement in profitability, with a 95.6% increase in profit. The company's net worth dipped by a decrease of 0.01%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Siomond Pharmaceuticals?
In 2016, Siomond Pharmaceuticals had a promoter holding of 78.62% and a public holding of 21.38%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ravilo Trade India Private LimitedActive 13 years 11 monthsPardeep Thakur and Mohan Thakur are mutual person
- Kaplin Enterprises Private LimitedActive 15 years 3 months
Pardeep Thakur and Mohan Thakur are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Overseas Bank Creation Date: 20 Aug 2010 | ₹30.00 Cr | Open |
State Bank Of India Creation Date: 14 Dec 2009 | ₹9.70 Cr | Satisfied |
State Bank Of India Creation Date: 23 Dec 2008 | ₹6.50 Cr | Satisfied |
How Many Employees Work at Siomond Pharmaceuticals?
Unlock and access historical data on people associated with Siomond Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Siomond Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Siomond Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
